Actively Recruiting
Molecular Analysis of Appendiceal Cancer Using DNA Methylation and m6A Epitranscriptomic Profiling for Better Risk Prediction
Led by City of Hope Medical Center · Updated on 2026-06-29
400
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating molecular features of appendiceal cancer, a rare and varied cancer type, by studying archived tumor tissue samples from patients. This study focuses on analyzing DNA methylation and m6A epitranscriptomic profiles to better understand molecular subtypes, their relationship to clinical features, and to develop risk scores for prognosis. The goal is to see if these molecular markers can add to traditional histologic grading and improve how risk is determined for patients. The study involves analyzing formalin-fixed paraffin-embedded appendiceal tumor tissues along with benign or normal appendix tissues where available. DNA methylation profiling evaluates tumor-related methylation patterns, differentially methylated regions, and their link to clinical outcomes. Simultaneously, m6A epitranscriptomic profiling uses RNA sequencing techniques to measure m6A enrichment across the transcriptome. These molecular data are combined to identify tumor-associated changes, classify molecular subtypes, and create risk scores that relate to pathology and patient outcomes. Participants contribute archived tumor or benign tissue samples along with clinical and follow-up data. Researchers assess overall survival and progression-free survival over about one year. The study includes detailed molecular and clinicopathologic data analysis without assigning treatments. The findings aim to enhance appendiceal cancer classification and prognostic modeling, supporting future biomarker development. The study runs through January 2027 with data collected mainly from existing tissue specimens.
CONDITIONS
Brief Title
Molecular Profiling for Risk Stratification in Appendiceal Cancer
Research Team
A
Ajay Goel
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here